Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer.

Saved in:
Bibliographic Details
Title: Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer.
Authors: Lloyd MR; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Weipert CM; Guardant Health, Inc., Redwood City, California., Ali A; Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, Ohio., Solomon SR; Guardant Health, Inc., Redwood City, California., Saha J; Guardant Health, Inc., Redwood City, California., Lipsyc-Sharf MD; UCLA Health Jonsson Comprehensive Cancer Center, Los Angeles, California., Hamilton EP; Sarah Cannon Research Institute, Nashville, Tennessee., Kalinsky K; Winship Cancer Institute at Emory University, Atlanta, Georgia., Brufsky AM; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Bardia A; UCLA Health Jonsson Comprehensive Cancer Center, Los Angeles, California., Zhang N; Guardant Health, Inc., Redwood City, California., Wander SA; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jan 06; Vol. 32 (1), pp. 169-178.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-25-3033